Announced Wed, 1 Jul · 11:34 IST
Anlon Healthcare to set up 2 new subsidiaries in pharma
Strategic Transactions View source PDF
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹16.03
prior close
₹16.16
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.1-0.2-0.2-0.8-1.1-4.2-3.1-3.8-2.9-7.4———
Up moveDown movePending
AI summary
Anlon Healthcare board approved incorporating two new subsidiaries: Anlon Medicare (55 percent stake, about Rs 11 lakh) for surgical implants and medical devices, and Anlon Biologics (65 percent stake, about Rs 6.5 lakh) for peptides, biosimilars and biological products. Both will be in India, funded by cash. Board also approved renaming existing subsidiary Remember India Health Links to Anlon Medicos, subject to MCA approval.
Likely market impact
Expands presence into implants, biosimilars and biologics segments. Initial investments are small, so no major financial impact expected in the near term.